Champions Oncology, Inc. (2I3)

Overview

Champions Oncology, Inc. is a groundbreaking research company in the United States that focuses on providing transformative technology solutions for drug discovery and development. The company stands out for its Tumorgraft Technology Platform, which pioneers in offering personalized cancer care by implanting human tumors in immune-deficient mice. This methodology not just positions Champions Oncology at the forefront of cancer research but also reflects its commitment towards innovating for more tailored and effective cancer treatments. Originally operating under the name Champions Biotechnology, Inc., the company underwent a name change to Champions Oncology, Inc. in April 2011, marking a pivotal transformation in its operational ethos and focus. Founded in 1985 and currently headquartered in Hackensack, New Jersey, Champions Oncology, Inc. employs a diverse marketing strategy that encompasses internet promotion, word-of-mouth endorsements, and a dedicated sales force, aiming to broaden its reach to patients and medical professionals alike.

Products and Services

• Tumorgraft Technology Platform

This innovative platform lies at the heart of Champions Oncology's initiatives, enabling personalized cancer treatment methodologies. It involves the implantation of human tumors into immune-deficient mice, which then serve as models for developing and testing cancer treatments. This process is designed to identify the most effective treatment paths tailored to individual patient profiles, thus improving the precision and efficacy of cancer care.

• Translational Oncology Solutions

Champions Oncology extends its technological prowess to assist pharmaceutical and biotechnology companies in their drug development processes. Through its Translational Oncology Solutions, the company leverages its Tumorgraft Technology Platform to facilitate the preclinical evaluation of new drugs, offering valuable insights into their efficacy and potential applications in oncology. This service fosters collaboration between Champions Oncology and drug developers, accelerating the journey from discovery to marketplace.

• Lumin Bioinformatics

As a testament to its commitment to harnessing the power of technology in cancer research, Champions Oncology offers Lumin Bioinformatics, a sophisticated analytic and visualization software. Designed for cancer biologists, this dynamic tool empowers users to leverage computational science in their research efforts. It facilitates the analysis and interpretation of complex biological data, enabling scientists to make informed decisions and foster advancements in the field of oncology. Lumin Bioinformatics stands out as a user-friendly yet powerful tool for modern cancer research endeavors.